Related Experiment Video
Updated: Apr 7, 2026
02:47
Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
Published on: May 12, 2023
2.1K
Cardiovascular pharmacogenomics: current status and future directions
1Vanderbilt University School of Medicine, Nashville, TN, USA.
Journal of Human Genetics
|July 17, 2015
Summary
Genetic factors significantly impact how individuals respond to common heart medications, leading to varied efficacy and side effects. Understanding these genomic influences can personalize cardiovascular drug therapy and identify new treatment targets.
Area of Science:
- Pharmacogenomics
- Cardiovascular Medicine
- Genetics
Background:
- Cardiovascular drugs are essential but show variable patient responses.
- Individual unpredictability in drug efficacy and adverse reactions is a clinical challenge.
- Genomic variations are increasingly recognized as a key factor in this variability.
Purpose of the Study:
- To review genomic factors influencing responses to cardiovascular drugs.
- To explore genomic approaches for discovering new cardiovascular disease pathways and drug targets.
- To discuss the integration of pharmacogenomic data into electronic medical records.
Main Methods:
- Literature review of studies on pharmacogenomics and cardiovascular drugs.
- Analysis of genomic approaches for identifying novel therapeutic targets.
- Discussion of electronic health record integration strategies.
Main Results:
- Genomic factors significantly explain variability in responses to drugs like clopidogrel, warfarin, heparin, and statins.
- Genomic research is uncovering new pathways and potential drug targets for cardiovascular diseases.
- Electronic medical records offer a platform for implementing personalized pharmacogenomic insights.
Conclusions:
- Pharmacogenomics is crucial for optimizing cardiovascular drug therapy.
- Genomic discoveries hold promise for developing more effective treatments for heart disease.
- Integrating genomic information into clinical practice, via electronic medical records, is essential for precision medicine.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
86
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
86
01:29Pharmacogenetics and Pharmacogenomics: Overview
158
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
158
01:27Pharmacogenetics of Drug Metabolism: Overview
131
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
131
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
116
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
116
01:27Principles of Pharmacogenetics: Types of Genetic Variants
102
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
102
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
69
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
69